Wuhan Easydiagnosis Biomedicine Co., Ltd. (002932)

Overview

Wuhan Easy Diagnosis Biomedicine Co.,Ltd., founded in 2008 and headquartered in Wuhan, China, operates in the biomedicine sector focusing on the development, manufacture, and sale of in-vitro diagnostic products. With a global presence, the company caters to a wide range of medical needs in both domestic and international markets. It specializes in providing innovative diagnostic solutions across various medical fields, including cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, and more. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. is also committed to offering comprehensive emergency and critical illness information solutions, alongside third-party medical inspection services.

Products and Services

• Molecular Diagnostic Products

  These include the PCR system, nucleic acid extraction and purification instrument, and sample release reagent, catering to the needs of molecular biology laboratories for accurate disease diagnosis.

• Blood Gas Analyzer

  This tool is essential for critical care and surgery, allowing healthcare providers to quickly assess a patient's respiratory and metabolic state.

• Immuno Diagnosis

  The range includes chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer, aimed at detecting immune responses for various diseases.

• Automatic Coagulation Analyzer

  Used for assessing clotting disorders, this analyzer is vital in hematology for diagnosing conditions such as thrombosis and hemophilia.

• Emergency and Critical Illness Information Solutions

  Comprehensive software, hardware, and consulting services designed to support healthcare institutions in managing critical patient care effectively.

• Third-party Medical Inspection Services

  Offering an external, unbiased examination of medical equipment and practices to ensure standards are met and maintained.

The company serves a diverse need in the healthcare sector, offering products and solutions across areas like cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, prenatal and postnatal care, health examination, thyroid disorders, hormones, blood gas and coagulation, drug metabolism, and pathogen detection, affirming its commitment to improving healthcare outcomes.